October 5th 2017




Regulatory Matters


Ensuring IVD Input Into Clinical Evidence
Rebecca Albrow
  Why is Harmonization and Standardization so Difficult?
Sverre Sandberg
  Panel Discussion
14.15–14.45 Coffee
14.45–16.30 The 'Omics" revolution
  The Economics of Genomics: "Cost versus Benefit"
Mario Pazzagli
  Has Lab on a Chip Arrived?
Albert van den Berg
  Liquid profiling (biopsy): a New Universe for Laboratory Medicine
Michael Neumaier
  Panel Discussion
16.30–17.00 Coffee
17.00–18.15 Power of Digitalization in Clinical Laboratories
– Sepehr Seyedzadeh, Siemens Healthineers (30 min.)
  Automation of the Clinical Laboratory
Martin Obermeier
  Panel Discussion
  TTA and TLA: Lab Evolution or Lab Revolution?
Rafael Pinto de Matos, Maksense
19.30 Welcome coctail
October 6th 2017
9:00–11:00 Adding Value
  Consolidation of Laboratory Activities is Necessary: Economic and Clinical Aspects
Burhard G. Piper – Limbach Gruppe
  Digital Pathology: Revolutionizing Histopathology
Uwe Schalles – Roche
  Revolution in the Laboratory: Patients as Customers
Wytze Oosterhuis
  Opportunities and Barriers to Merging Public Service Medical Laboratories
Ian Watson
11.00–11.30 Coffee
11.30–13.00 Delivering Quality
  Solving Practical Problems: What Colour Should Blood-Tube Tops Be? An Industry & Profession Partnership
Ana-Maria Simundic and Stephen Church
  How Can Business Intelligence Optimize Hospital Laboratory Workflow´s and Deliver a Valid Contribution to Improve Quality Medicine and the Overall Profitability
Alexander Hoffmann, Abbott Laboratories
  What Metrics Meaningfully Measure Lab Performance?
Mario Plebani
13.00–13.30 Discussion / Future Perspectives
13.30–13.45 Closing remarks
13.45 Lunch